Research Article

Frequency of Drug Resistance Gene Amplification in Clinical Leishmania Strains

Table 2

Main characteristics of the isolates and results of relative quantification of resistance genes for Sudanese patients. All patients were visceral leishmaniasis patients except S28, S29, and S30 who presented with post kala-azar dermal leishmaniasis. NA: nonamplified.

PatientsParasite identificationSite of isolationPGPMDRGSHDHFRPTR1

S1L. donovani MON 18lymph node0.981.210.851.011.03
S2L. donovani MON 18lymph node4.4719.42.930.931.49
S3L. donovani MON 18lymph node1.282.710.920.980.85
S4L. donovani MON 18lymph node0.781.211.041.032.03
S5L. donovani MON 18lymph node0.976.161.611.021.03
S6L. donovani MON 18lymph node0.85.490.620.750.86
S7L. donovani MON 18lymph node0.82NA1.021.051.02
S8L. donovani MON 18lymph nodeNA0.960.85NA0.91
S9L. donovani MON 18lymph nodeNA0.780.95NA0.85
S10L. donovani MON 18lymph node1.050.990.611.021.05
S11L. donovani MON 18lymph node4.541.020.69NANA
S12L. donovani MON 18lymph node1.521.48NA1.070.98
s 13L. donovani MON 18lymph node1.071.74NANANA
S14L. donovani MON 18lymph node1.172.721.040.982.7
S15L. donovani MON 18lymph node0.944.680.950.950.86
S16L. archibaldi MON 257lymph node0.870.981.041.02NA
S17L. archibaldi MON 257lymph node0.815.250.721.051.04
S18L. archibaldi MON 258lymph node1.062.70.770.97NA
S19L. archibaldi MON 257lymph node0.921.330.980.850.83
S20L. archibaldi MON 257lymph node1.134.470.791.03NA
S21L. archibaldi MON 257lymph node1.552.240.870.93NA
S22L. infantum MON 30lymph node7.833.621.120.830.97
S23L. infantum MON 30lymph node0.991.740.770.92NA
S24L. infantum MON 30lymph node0.722.961.040.730.68
S25L. infantum MON 30lymph node1.323.120.670.94NA
S26L. infantum MON 30lymph node1.041.031.011.02NA
S27L. infantum MON 30lymph node0.780.960.971.05NA
S28L. infantum MON 267skin0.937.132.480.95NA
S29L. donovani MON 18skin0.941.511.031.04NA
S30L. donovani MON 18skin22.262.81.830.631.1